메뉴 건너뛰기




Volumn 16, Issue 5, 2013, Pages 987-995

Metabolic risk factors in first-episode schizophrenia: Baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial

Author keywords

Antipsychotic; antipsychotic naive; first episode; metabolic syndrome; schizophrenia

Indexed keywords

AMISULPRIDE; CHOLESTEROL; HALOPERIDOL; HIGH DENSITY LIPOPROTEIN; OLANZAPINE; QUETIAPINE; TRIACYLGLYCEROL; ZIPRASIDONE;

EID: 84877996294     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001241     Document Type: Article
Times cited : (76)

References (46)
  • 1
    • 0344442356 scopus 로고    scopus 로고
    • The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: The French D. E. S.I. R. study
    • Balkau B, Vernay M, Mhamdi L, Novak M, et al., (2003) The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: the French D. E. S.I. R. study. Diabetes Metab 29:526-532.
    • (2003) Diabetes Metab , vol.29 , pp. 526-532
    • Balkau, B.1    Vernay, M.2    Mhamdi, L.3    Novak, M.4
  • 2
    • 58249135655 scopus 로고    scopus 로고
    • Course of illness in a sample of 265 patients with first-episode psychosis-five year follow-up of the Danish OPUS trials
    • Bertelsen M, Jeppesen P, Petersen L, Thorup A, et al., (2009) Course of illness in a sample of 265 patients with first-episode psychosis-five year follow-up of the Danish OPUS trials. Schizophr Res 107:173-178.
    • (2009) Schizophr Res , vol.107 , pp. 173-178
    • Bertelsen, M.1    Jeppesen, P.2    Petersen, L.3    Thorup, A.4
  • 3
    • 33846624634 scopus 로고    scopus 로고
    • Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS study
    • Bobes J, Arango C, Aranda P, Carmena R, et al., (2007) Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS study. Schizophr Res 90:162-173.
    • (2007) Schizophr Res , vol.90 , pp. 162-173
    • Bobes, J.1    Arango, C.2    Aranda, P.3    Carmena, R.4
  • 4
    • 77950307734 scopus 로고    scopus 로고
    • Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: Findings from the CLAMORS study
    • Bobes J, Arango C, Rejas J, for the CLAMORS Study Collaborative Group (2010) Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry 71:280-286.
    • (2010) J Clin Psychiatry , vol.71 , pp. 280-286
    • Bobes, J.1    Arango, C.2    Rejas, J.3
  • 5
    • 70350738289 scopus 로고    scopus 로고
    • Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
    • Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, et al., (2009) Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. J Am Med Assoc 302:1765-1773.
    • (2009) J Am Med Assoc , vol.302 , pp. 1765-1773
    • Correll, C.U.1    Manu, P.2    Olshanskiy, V.3    Napolitano, B.4    Kane, J.M.5
  • 6
    • 84856466929 scopus 로고    scopus 로고
    • Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
    • De Hert M, Detraux J, van Winkel R, Yu W, et al., (2012) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8:114-126.
    • (2012) Nat Rev Endocrinol , vol.8 , pp. 114-126
    • De Hert, M.1    Detraux, J.2    Van Winkel, R.3    Yu, W.4
  • 7
    • 33646679115 scopus 로고    scopus 로고
    • Metabolic abnormalities associated with second generation antipsychotics: Facts or fiction? Development of guidelines for screening and monitoring
    • De Hert M, van Eyck D, De Nayer A (2006) Metabolic abnormalities associated with second generation antipsychotics: facts or fiction? Development of guidelines for screening and monitoring. Int Clin Psychopharmacol 21(Suppl. 2):S11-S15.
    • (2006) Int Clin Psychopharmacol , vol.21 , Issue.SUPPL. 2
    • De Hert, M.1    Van Eyck, D.2    De Nayer, A.3
  • 8
    • 43049144928 scopus 로고    scopus 로고
    • Typical and atypical antipsychotics differentially affect longterm incidence rates of the metabolic syndrome in firstepisode patients with schizophrenia: A retrospective chart review
    • De Hert MD, Schreurs V, Sweers K, Van Eyck D, et al., (2008) Typical and atypical antipsychotics differentially affect longterm incidence rates of the metabolic syndrome in firstepisode patients with schizophrenia: a retrospective chart review. Schizophr Res 100:295-303.
    • (2008) Schizophr Res , vol.100 , pp. 295-303
    • De Hert, M.D.1    Schreurs, V.2    Sweers, K.3    Van Eyck, D.4
  • 9
    • 56749102985 scopus 로고    scopus 로고
    • Identifying metabolic syndrome without blood tests in young adults-the Terneuzen birth cohort
    • de Kroon MLA, Renders CM, Kupiers ECC, van Wouwe JP, et al., (2008) Identifying metabolic syndrome without blood tests in young adults-the Terneuzen birth cohort. Eur J Public Health 18:656-660.
    • (2008) Eur J Public Health , vol.18 , pp. 656-660
    • De Kroon, M.L.A.1    Renders, C.M.2    Kupiers, E.C.C.3    Van Wouwe, J.P.4
  • 10
    • 33845886915 scopus 로고    scopus 로고
    • Abdominal obesity and metabolic syndrome
    • Despres JP, Lemieus I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881-887.
    • (2006) Nature , vol.444 , pp. 881-887
    • Despres, J.P.1    Lemieus, I.2
  • 12
    • 84865627930 scopus 로고    scopus 로고
    • Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity and body mass index
    • Ervin RB (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity and body mass index. Natl Health Stat Rep 13:1-7.
    • (2009) Natl Health Stat Rep , vol.13 , pp. 1-7
    • Ervin, R.B.1
  • 14
    • 44849100969 scopus 로고    scopus 로고
    • Comorbid somatic illnesses in patients with severe mental disorders: Clinical, policy, and research challenges
    • Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, et al., (2008) Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry 69:514-519.
    • (2008) J Clin Psychiatry , vol.69 , pp. 514-519
    • Fleischhacker, W.W.1    Cetkovich-Bakmas, M.2    De Hert, M.3    Hennekens, C.H.4
  • 15
    • 24344442805 scopus 로고    scopus 로고
    • The European first episode schizophrenia trial (EUFEST): Rationale and design of the trial
    • Fleischhacker WW, Keet IP, Kahn RS (2005) The European first episode schizophrenia trial (EUFEST): rationale and design of the trial. Schizophr Res 7:147-156.
    • (2005) Schizophr Res , vol.7 , pp. 147-156
    • Fleischhacker, W.W.1    Keet, I.P.2    Kahn, R.S.3
  • 16
    • 0037116641 scopus 로고    scopus 로고
    • Prevalence of metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey
    • Ford ES, Giles WH, Dietz WH (2002) Prevalence of metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. J Am Med Assoc 287:356-359.
    • (2002) J Am Med Assoc , vol.287 , pp. 356-359
    • Ford, E.S.1    Giles, W.H.2    Dietz, W.H.3
  • 17
    • 77955057397 scopus 로고    scopus 로고
    • Metabolic syndrome associated with schizophrenia and atypical antipsychotics
    • Hasnain M, Fredrickson SK, Vieweg WV, Pandurangi AK (2010) Metabolic syndrome associated with schizophrenia and atypical antipsychotics. Curr Diab Rep 10:209-216.
    • (2010) Curr Diab Rep , vol.10 , pp. 209-216
    • Hasnain, M.1    Fredrickson, S.K.2    Vieweg, W.V.3    Pandurangi, A.K.4
  • 18
    • 79956072601 scopus 로고    scopus 로고
    • Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study
    • Johnsen E, Gjestad R, Kroken RA, Mellesdal L et al., (2011) Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study. Nord J Psychiatry 65:192-202.
    • (2011) Nord J Psychiatry , vol.65 , pp. 192-202
    • Johnsen, E.1    Gjestad, R.2    Kroken, R.A.3    Mellesdal, L.4
  • 19
  • 20
    • 44649131269 scopus 로고    scopus 로고
    • Metabolic syndrome-what is the clinical usefulness?
    • Kahn R (2008) Metabolic syndrome-what is the clinical usefulness? Lancet 371:1892-1893.
    • (2008) Lancet , vol.371 , pp. 1892-1893
    • Kahn, R.1
  • 21
    • 40949142200 scopus 로고    scopus 로고
    • Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: An open randomized clinical trial
    • Kahn RS, Fleischhacker WW, Boter H, Davidson M, et al. for the EUFEST study group (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomized clinical trial. Lancet 371:1085-1097.
    • (2008) Lancet , vol.371 , pp. 1085-1097
    • Kahn, R.S.1    Fleischhacker, W.W.2    Boter, H.3    Davidson, M.4
  • 22
    • 77955155398 scopus 로고    scopus 로고
    • Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults United States 1999-2006
    • Kulina EV, Yoon PW, Keenan NL (2010) Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults, United States, 1999-2006. Ann Fam Med 8:327-333.
    • (2010) Ann Fam Med , vol.8 , pp. 327-333
    • Kulina, E.V.1    Yoon, P.W.2    Keenan, N.L.3
  • 23
    • 0035040066 scopus 로고    scopus 로고
    • The clinical implications of weight gain in schizophrenia
    • Kurzthaler I, Fleischhacker WW (2001) The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 62(Suppl. 7):32-37.
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 7 , pp. 32-37
    • Kurzthaler, I.1    Fleischhacker, W.W.2
  • 24
    • 25144456112 scopus 로고    scopus 로고
    • Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
    • Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, et al. for the Clinical Antipsychotic Trials of Intervention Effectiveness Investigators (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Eng J Med 35:1209-1223.
    • (2005) N Eng J Med , vol.35 , pp. 1209-1223
    • Lieberman, J.A.1    Stroup, T.S.2    McEvoy, J.P.3    Swartz, M.S.4
  • 25
    • 27744502054 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia trial and comparison with national estimates from NHANES III
    • McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, et al., (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 80:19-32.
    • (2005) Schizophr Res , vol.80 , pp. 19-32
    • McEvoy, J.P.1    Meyer, J.M.2    Goff, D.C.3    Nasrallah, H.A.4
  • 26
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, et al., (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3
  • 27
    • 41149131177 scopus 로고    scopus 로고
    • Arterial structure and function in young adults with the metabolic syndrome: The Cardiovascular Risk in Young Finns Study
    • Mattsson N, Ronnemaa T, Juonala M, Viikari JSA, et al., (2008) Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study. Eur Heart J 29:784-791.
    • (2008) Eur Heart J , vol.29 , pp. 784-791
    • Mattsson, N.1    Ronnemaa, T.2    Juonala, M.3    Viikari, J.S.A.4
  • 28
    • 27744456032 scopus 로고    scopus 로고
    • The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
    • Meyer JM, Nesrallah HA, McEvoy Goff DC, et al., (2005) The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res 80:9-18.
    • (2005) Schizophr Res , vol.80 , pp. 9-18
    • Meyer, J.M.1    Nesrallah, H.A.2    McEvoy Goff, D.C.3
  • 29
    • 84874544333 scopus 로고    scopus 로고
    • Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-A systematic review and meta-analysis
    • Published online: 29 December 2011. doi :10.1093/schbul/sbr148
    • Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, et al., (2011) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-A systematic review and meta-analysis. Schizophr Bull. Published online: 29 December 2011. doi :10.1093/schbul/sbr148.
    • (2011) Schizophr Bull
    • Mitchell, A.J.1    Vancampfort, D.2    Sweers, K.3    Van Winkel, R.4
  • 30
    • 84874513990 scopus 로고    scopus 로고
    • Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients
    • Published online: 27 August 2011. doi:10.1093/schbul/sbs082
    • Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M (2012a) Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull Published online: 27 August 2011. doi:10.1093/schbul/sbs082.
    • (2012) Schizophr Bull
    • Mitchell, A.J.1    Vancampfort, D.2    De Herdt, A.3    Yu, W.4    De Hert, M.5
  • 31
    • 82555172404 scopus 로고    scopus 로고
    • Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices
    • Mitchell AJ, Delaffon V, Vancampfort D, Correll CU, et al., (2012b) Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 42:125-147.
    • (2012) Psychol Med , vol.42 , pp. 125-147
    • Mitchell, A.J.1    Delaffon, V.2    Vancampfort, D.3    Correll, C.U.4
  • 32
    • 79951704858 scopus 로고    scopus 로고
    • Persistent increase of prevalence of metabolic syndrome among us adults: NHANES III to NHANES 1999-2006
    • Mozumdar A, Liguori G (2011) Persistent increase of prevalence of metabolic syndrome among us adults: NHANES III to NHANES 1999-2006. Diabetes Care 34:216-219.
    • (2011) Diabetes Care , vol.34 , pp. 216-219
    • Mozumdar, A.1    Liguori, G.2
  • 33
    • 84891629662 scopus 로고    scopus 로고
    • The metabolic effects of antipsychotic medications
    • Newcomer JW, Haupt DW (2006) The metabolic effects of antipsychotic medications. Can J Psychiatry 59:337-345.
    • (2006) Can J Psychiatry , vol.59 , pp. 337-345
    • Newcomer, J.W.1    Haupt, D.W.2
  • 34
    • 35348960372 scopus 로고    scopus 로고
    • Severe mental illness and risk of cardiovascular disease
    • Newcomer JW, Hennekens CH (2007) Severe mental illness and risk of cardiovascular disease. J Am Med Assoc 298:1794-1796.
    • (2007) J Am Med Assoc , vol.298 , pp. 1794-1796
    • Newcomer, J.W.1    Hennekens, C.H.2
  • 35
    • 77954762965 scopus 로고    scopus 로고
    • Antipsychotics associated with the development of type 2 diabetes in antipsychotic-näive schizophrenia patients
    • Nielsen J, Skadhede S, Correll CU (2010) Antipsychotics associated with the development of type 2 diabetes in antipsychotic-näive schizophrenia patients. Neuropsychopharmacology 35:1997-2004.
    • (2010) Neuropsychopharmacology , vol.35 , pp. 1997-2004
    • Nielsen, J.1    Skadhede, S.2    Correll, C.U.3
  • 36
    • 67349136738 scopus 로고    scopus 로고
    • Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
    • Patel JK, Buckley PF, Woolson S, Hamer RM, et al., (2009) Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res 111:9-16.
    • (2009) Schizophr Res , vol.111 , pp. 9-16
    • Patel, J.K.1    Buckley, P.F.2    Woolson, S.3    Hamer, R.M.4
  • 37
    • 70449440638 scopus 로고    scopus 로고
    • Dropouts and missing data in psychiatric clinical trials
    • Potkin SG, Siu CO (2009) Dropouts and missing data in psychiatric clinical trials. Am J Psychiatry 166:1295.
    • (2009) Am J Psychiatry , vol.166 , pp. 1295
    • Potkin, S.G.1    Siu, C.O.2
  • 38
    • 19644394512 scopus 로고    scopus 로고
    • The metabolic syndrome: Requiescat in pace
    • Reaven GM (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51:931-938.
    • (2005) Clin Chem , vol.51 , pp. 931-938
    • Reaven, G.M.1
  • 39
    • 34948840329 scopus 로고    scopus 로고
    • A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?
    • Saha S, Chant D, McGrath J (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64:1123-1131.
    • (2007) Arch Gen Psychiatry , vol.64 , pp. 1123-1131
    • Saha, S.1    Chant, D.2    McGrath, J.3
  • 40
    • 43049125770 scopus 로고    scopus 로고
    • Metabolic syndrome in first-episode schizophrenia-A randomized, double-blind controlled, short-term prospective study
    • Saddichha S, Manjunatha N, Ameen S, Akhtar S (2008) Metabolic syndrome in first-episode schizophrenia-a randomized, double-blind controlled, short-term prospective study. Schizophr Res 101:266-272.
    • (2008) Schizophr Res , vol.101 , pp. 266-272
    • Saddichha, S.1    Manjunatha, N.2    Ameen, S.3    Akhtar, S.4
  • 41
    • 0032421570 scopus 로고    scopus 로고
    • The mini-international neuropsychiatric interview (M. I. N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
    • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, et al., (1998) The mini-international neuropsychiatric interview (M. I. N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl. 20):22-33.
    • (1998) J Clin Psychiatry , vol.59 , Issue.SUPPL. 20 , pp. 22-33
    • Sheehan, D.V.1    Lecrubier, Y.2    Sheehan, K.H.3    Amorim, P.4
  • 42
    • 0034686717 scopus 로고    scopus 로고
    • Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity
    • Stamler J, Daviglus ML, Garside DB, Dyer AR, et al., (2000) Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. J Am Med Assoc 284:311-318.
    • (2000) J Am Med Assoc , vol.284 , pp. 311-318
    • Stamler, J.1    Daviglus, M.L.2    Garside, D.B.3    Dyer, A.R.4
  • 43
    • 34447341958 scopus 로고    scopus 로고
    • Metabolic side effects of antipsychotic medication
    • Tschoner A, Engl J, Laimer M, Kaser S, et al., (2007) Metabolic side effects of antipsychotic medication. Int J Clin Pract 18:1356-1370.
    • (2007) Int J Clin Pract , vol.18 , pp. 1356-1370
    • Tschoner, A.1    Engl, J.2    Laimer, M.3    Kaser, S.4
  • 44
    • 0141755326 scopus 로고    scopus 로고
    • Insulin sensitivity, insulin secretion and abdominal fat: The insulin resistance atherosclerosis study (IRAS) family study
    • Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, et al., (2003) Insulin sensitivity, insulin secretion and abdominal fat: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 52:2490-2496.
    • (2003) Diabetes , vol.52 , pp. 2490-2496
    • Wagenknecht, L.E.1    Langefeld, C.D.2    Scherzinger, A.L.3    Norris, J.M.4
  • 45
    • 0032013736 scopus 로고    scopus 로고
    • The design and analysis of longitudinal studies of development and psychopathology in context: Statistical models and methodological recommendations
    • Willett JB, Singer JD, Martin NC (1998) The design and analysis of longitudinal studies of development and psychopathology in context: statistical models and methodological recommendations. Dev Psychopathol 10:395-426.
    • (1998) Dev Psychopathol , vol.10 , pp. 395-426
    • Willett, J.B.1    Singer, J.D.2    Martin, N.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.